References
Cheng J, Holland-Letz T, Wallwiener M et al (2018) Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-018-4666-5
Liang DH, Ensor JE, Liu ZB et al (2016) Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients. Breast Cancer Res Treat 155(1):139–149
Maltoni R, Casadio V, Ravaioli S et al (2017) Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer. Oncotarget 8(10):16642–16649
Author information
Authors and Affiliations
Corresponding author
Additional information
This letter to the editor refers to the article available at https://doi.org/10.1007/s10549-018-4666-5 and a rebuttal letter to this letter to the editor is available at https://doi.org/10.1007/s10549-018-4731-0.
Rights and permissions
About this article
Cite this article
Bronte, G., Ravaioli, S. & Bravaccini, S. What to look for in cell-free DNA from breast cancer patients. Breast Cancer Res Treat 170, 199–200 (2018). https://doi.org/10.1007/s10549-018-4728-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-018-4728-8